Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endophthalmitis | 4 | 2020 | 84 | 2.360 |
Why?
|
| Cataract Extraction | 4 | 2020 | 184 | 1.880 |
Why?
|
| Eye Infections, Bacterial | 3 | 2020 | 96 | 1.780 |
Why?
|
| Cataract | 4 | 2022 | 218 | 1.480 |
Why?
|
| Retinal Detachment | 2 | 2022 | 88 | 1.430 |
Why?
|
| Vitreous Body | 3 | 2017 | 123 | 1.220 |
Why?
|
| Perioperative Care | 3 | 2020 | 454 | 1.180 |
Why?
|
| Visual Acuity | 8 | 2020 | 864 | 1.170 |
Why?
|
| Tomography, Optical Coherence | 5 | 2020 | 502 | 1.140 |
Why?
|
| Diabetic Retinopathy | 3 | 2020 | 178 | 1.010 |
Why?
|
| Diabetes Mellitus | 2 | 2020 | 1066 | 0.760 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2020 | 181 | 0.730 |
Why?
|
| Vitrectomy | 6 | 2022 | 100 | 0.710 |
Why?
|
| Multifocal Intraocular Lenses | 1 | 2020 | 13 | 0.710 |
Why?
|
| Cytomegalovirus Retinitis | 1 | 2019 | 16 | 0.680 |
Why?
|
| Osteoma | 1 | 2018 | 8 | 0.680 |
Why?
|
| Eye Infections, Viral | 1 | 2019 | 30 | 0.670 |
Why?
|
| Choroid | 1 | 2018 | 35 | 0.660 |
Why?
|
| Choroid Neoplasms | 1 | 2018 | 41 | 0.650 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 94 | 0.650 |
Why?
|
| Choroidal Neovascularization | 1 | 2018 | 29 | 0.650 |
Why?
|
| Macular Edema | 1 | 2020 | 99 | 0.640 |
Why?
|
| Eye Diseases | 1 | 2020 | 132 | 0.640 |
Why?
|
| Viremia | 1 | 2019 | 178 | 0.640 |
Why?
|
| Sclera | 1 | 2018 | 64 | 0.630 |
Why?
|
| Optic Nerve Diseases | 1 | 2019 | 103 | 0.610 |
Why?
|
| Eye Infections, Fungal | 2 | 2019 | 72 | 0.580 |
Why?
|
| Ophthalmology | 1 | 2020 | 198 | 0.580 |
Why?
|
| Vitreoretinal Surgery | 1 | 2016 | 7 | 0.550 |
Why?
|
| Suture Techniques | 1 | 2018 | 322 | 0.550 |
Why?
|
| Cytomegalovirus | 1 | 2019 | 474 | 0.540 |
Why?
|
| Postoperative Complications | 7 | 2022 | 5567 | 0.530 |
Why?
|
| Fungi | 1 | 2016 | 146 | 0.520 |
Why?
|
| Lens Implantation, Intraocular | 1 | 2018 | 314 | 0.510 |
Why?
|
| Cost-Benefit Analysis | 4 | 2020 | 948 | 0.500 |
Why?
|
| Betacoronavirus | 1 | 2020 | 524 | 0.480 |
Why?
|
| Intravitreal Injections | 3 | 2020 | 141 | 0.470 |
Why?
|
| Lenses, Intraocular | 1 | 2018 | 346 | 0.460 |
Why?
|
| Microsurgery | 1 | 2016 | 243 | 0.450 |
Why?
|
| Retinal Diseases | 1 | 2016 | 179 | 0.450 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 647 | 0.400 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 711 | 0.400 |
Why?
|
| Bacteria | 1 | 2016 | 611 | 0.400 |
Why?
|
| Anti-Bacterial Agents | 3 | 2020 | 2992 | 0.400 |
Why?
|
| Eye Abnormalities | 1 | 2012 | 118 | 0.390 |
Why?
|
| Retinoschisis | 1 | 2010 | 7 | 0.380 |
Why?
|
| Pandemics | 1 | 2020 | 1564 | 0.370 |
Why?
|
| Fluorescein Angiography | 2 | 2022 | 140 | 0.360 |
Why?
|
| Fuchs' Endothelial Dystrophy | 2 | 2019 | 8 | 0.350 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2012 | 826 | 0.290 |
Why?
|
| Fundus Oculi | 2 | 2019 | 75 | 0.260 |
Why?
|
| Humans | 23 | 2022 | 262248 | 0.240 |
Why?
|
| Cornea | 2 | 2019 | 634 | 0.230 |
Why?
|
| Descemet Stripping Endothelial Keratoplasty | 2 | 2019 | 12 | 0.210 |
Why?
|
| Antifungal Agents | 2 | 2019 | 840 | 0.210 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2022 | 67 | 0.200 |
Why?
|
| Organ Preservation Solutions | 1 | 2019 | 20 | 0.180 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2019 | 6932 | 0.170 |
Why?
|
| Medicare | 2 | 2022 | 898 | 0.170 |
Why?
|
| Descemet Membrane | 1 | 2018 | 10 | 0.170 |
Why?
|
| Preoperative Period | 1 | 2020 | 344 | 0.170 |
Why?
|
| Optic Atrophy | 1 | 2019 | 46 | 0.170 |
Why?
|
| Cryopreservation | 1 | 2019 | 174 | 0.160 |
Why?
|
| Ganciclovir | 1 | 2019 | 175 | 0.160 |
Why?
|
| Endothelium, Corneal | 1 | 2018 | 33 | 0.160 |
Why?
|
| Aged | 9 | 2022 | 70367 | 0.160 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2019 | 104 | 0.160 |
Why?
|
| Artificial Organs | 1 | 2017 | 5 | 0.150 |
Why?
|
| Amikacin | 1 | 2016 | 34 | 0.140 |
Why?
|
| Male | 9 | 2020 | 123338 | 0.130 |
Why?
|
| Glaucoma | 1 | 2016 | 92 | 0.130 |
Why?
|
| Prosthesis Implantation | 1 | 2017 | 265 | 0.120 |
Why?
|
| Vancomycin | 1 | 2016 | 274 | 0.120 |
Why?
|
| Bone Marrow Transplantation | 1 | 2019 | 1639 | 0.110 |
Why?
|
| Comorbidity | 1 | 2020 | 2397 | 0.110 |
Why?
|
| Abortion, Therapeutic | 1 | 2012 | 5 | 0.110 |
Why?
|
| Persistent Hyperplastic Primary Vitreous | 1 | 2012 | 2 | 0.110 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2016 | 996 | 0.110 |
Why?
|
| Eye Evisceration | 1 | 2012 | 7 | 0.110 |
Why?
|
| Retrospective Studies | 4 | 2020 | 38011 | 0.110 |
Why?
|
| Coloboma | 1 | 2012 | 43 | 0.100 |
Why?
|
| Microphthalmos | 1 | 2012 | 57 | 0.100 |
Why?
|
| Ultrasonography | 1 | 2018 | 1869 | 0.100 |
Why?
|
| Fibrosarcoma | 1 | 2012 | 134 | 0.100 |
Why?
|
| Antiviral Agents | 1 | 2019 | 1234 | 0.100 |
Why?
|
| Female | 7 | 2018 | 142293 | 0.100 |
Why?
|
| Orbit | 1 | 2012 | 206 | 0.100 |
Why?
|
| Orbital Neoplasms | 1 | 2012 | 225 | 0.090 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 4745 | 0.080 |
Why?
|
| Gestational Age | 1 | 2012 | 1064 | 0.080 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 29996 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2012 | 927 | 0.070 |
Why?
|
| Adolescent | 2 | 2018 | 31239 | 0.070 |
Why?
|
| Adult | 4 | 2018 | 78179 | 0.070 |
Why?
|
| Child | 2 | 2019 | 29067 | 0.070 |
Why?
|
| Middle Aged | 4 | 2018 | 86544 | 0.070 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 14913 | 0.060 |
Why?
|
| Reimbursement Mechanisms | 1 | 2022 | 78 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2010 | 1359 | 0.050 |
Why?
|
| Keratoplasty, Penetrating | 1 | 2019 | 47 | 0.040 |
Why?
|
| Disease Progression | 1 | 2010 | 6693 | 0.040 |
Why?
|
| Voriconazole | 1 | 2019 | 108 | 0.040 |
Why?
|
| Amphotericin B | 1 | 2019 | 289 | 0.040 |
Why?
|
| Drug Costs | 1 | 2019 | 145 | 0.040 |
Why?
|
| Health Services Research | 1 | 2019 | 233 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2019 | 621 | 0.040 |
Why?
|
| Aphakia, Postcataract | 1 | 2017 | 19 | 0.040 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2018 | 235 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 7717 | 0.030 |
Why?
|
| Prostheses and Implants | 1 | 2017 | 295 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2018 | 790 | 0.030 |
Why?
|
| Young Adult | 1 | 2012 | 21494 | 0.030 |
Why?
|
| United States | 2 | 2022 | 15574 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 15874 | 0.020 |
Why?
|